Measurement & Valuation

IFRS 2 Cash-Settled Share-Based Payments: Measurement and Re-measurement

Lux Actuaries4 min read

Share-based payment arrangements are a common way for companies to reward employees and executives, aligning their interests with shareholders. While many people think of these as equity-settled (where employees receive shares), a significant category involves cash-settled arrangements. These are distinct because the company commits to paying cash, the amount of which is linked to the value of its own equity instruments. Under IFRS 2 Share-based Payment, the accounting for these cash-settled liabilities requires specific attention, particularly concerning their measurement and re-measurement.

Initial Measurement: Establishing the Baseline

When a company grants cash-settled share-based payments, it creates a liability. The first step in accounting for this liability is its initial measurement. IFRS 2 mandates that this liability be measured at its fair value at the grant date. This fair value is then expensed over the vesting period, with a corresponding liability recognized on the balance sheet. For example, if a company grants share appreciation rights (SARs) that vest over three years, one-third of the fair value at grant date would typically be recognized as an expense and liability each year.

Determining this initial fair value usually involves complex option pricing models, such as the Black-Scholes model or binomial models, tailored to the specific terms and conditions of the award. These models consider factors like the current share price, exercise price, expected volatility of the share price, expected dividends, and the risk-free interest rate.

The Continuous Journey: Re-measurement

Unlike equity-settled share-based payments, where the fair value determined at grant date is generally fixed for expense recognition, cash-settled awards are fundamentally different. Because the company is obliged to pay cash whose value fluctuates with the share price, the liability itself must reflect this ongoing uncertainty.

Therefore, at each reporting date (e.g., quarterly or annually) until the liability is settled, IFRS 2 requires the company to re-measure the fair value of the outstanding cash-settled share-based payment liability. This means revisiting the valuation model with updated inputs, most notably the current market share price. If the company's share price increases, the fair value of the liability will likely increase, and vice-versa.

Impact on Profit or Loss

The most significant consequence of this continuous re-measurement is how changes in fair value are recognized. Any increase or decrease in the fair value of the liability from the previous reporting date (or grant date for the first measurement) is recognized directly in profit or loss. This means that fluctuations in a company's share price can lead to significant and potentially volatile movements in its reported profit or loss, even before the awards are exercised or paid out.

For instance, if a company's share price skyrockets after granting SARs, the fair value of its cash-settled liability will increase, resulting in a larger expense recognized in profit or loss. Conversely, a drop in share price would lead to a reduction in the liability and a corresponding gain in profit or loss. This direct link to market fluctuations introduces a dynamic element to the financial statements that requires careful monitoring and understanding.

Actuarial Expertise is Key

The complexity of fair value determination, both initially and at each re-measurement date, often necessitates the involvement of actuarial professionals. Their expertise in valuation methodologies and understanding of market dynamics is crucial to accurately reflecting these liabilities on the financial statements and ensuring compliance with IFRS 2.

Conclusion

In essence, cash-settled share-based payment liabilities are a moving target. While initially measured at fair value at the grant date, their subsequent accounting is marked by continuous re-measurement through profit or loss until settlement. This distinctive feature ensures that the financial statements always reflect the current economic reality of the company's obligation, albeit with potential for considerable volatility. For finance professionals, understanding this ongoing measurement and re-measurement cycle is paramount for accurate financial reporting and analysis.

Need Help With Your IFRS 2 Valuation?

Our qualified actuaries can help you with discount rate selection, assumption setting, and full IFRS 2 valuations.

Get a Quote